FullStem specializes in high-density mass culture technology for stem cells, utilizing a patented non-woven fabric scaffold to enable efficient and automated cultivation and recovery of over 1 billion therapeutic cells in a single operation. This technology addresses the challenges of high costs and labor-intensive processes in stem cell therapy, making it accessible for clinical use.
Funding
Funding not disclosed
Founders
Product
Problem
Stem cell therapies are often expensive and labor-intensive, requiring specialized equipment and trained personnel to produce sufficient quantities of cells for clinical use. Traditional methods struggle to achieve the cell densities needed for efficient and scalable production, hindering widespread adoption.
Solution
FullStem offers a high-density mass culture technology for stem cells, leveraging a patented non-woven fabric scaffold to enable efficient and automated cultivation. This platform facilitates the production and recovery of over 1 billion therapeutic cells in a single operation, significantly reducing labor and costs. The technology aims to make stem cell therapy more accessible by providing a compact, safe, and easy-to-use system suitable for clinical settings. FullStem's approach simplifies the complex process of stem cell expansion, ensuring high-quality cells are readily available for various therapeutic applications.
Target Audience
The primary target audience includes regenerative medicine clinics, research institutions, and cell therapy manufacturers seeking efficient and cost-effective stem cell production solutions.
Features
- Patented non-woven fabric scaffold for high-density 3D cell culture
- Automated cell cultivation and recovery system
- Scalable production of over 1 billion cells per operation
- Compact and user-friendly design for easy integration into clinical workflows
- Optimized protocols and culture kits for various stem cell types
- Enhanced cell quality and exosome production compared to traditional methods